M&A - Hillenbrand, Inc.
Form Type: 8-K
Filing Date: 2025-03-31
Corporate Action: Acquisition
Type: New
Accession Number: 000141739825000106
Filing Summary: On March 31, 2025, Hillenbrand, Inc. announced the closing of the previously disclosed sale of the majority ownership in its Milacron injection molding and extrusion business. This transaction represents a significant shift in the company's operational focus and strategic direction, aligning with its long-term goals. A press release detailing the transaction was issued and can be found as Exhibit 99.1 to this Current Report on Form 8-K.
Additional details:
Date Of Report: 2025-03-31
Business Sold: Milacron injection molding and extrusion business
Exhibit 99 1: Press Release, dated as of March 31, 2025, issued by the Company
Form Type: 8-K
Filing Date: 2025-02-05
Corporate Action: Acquisition
Type: New
Accession Number: 000141739825000059
Filing Summary: On February 5, 2025, Hillenbrand, Inc. entered into a Contribution and Purchase Agreement with BCSS Iota (A), LLC, an affiliate of Bain Capital, for the acquisition of majority ownership in Hillenbrand's Milacron injection molding and extrusion business. The agreement outlines that prior to the deal's closing, Hillenbrand's subsidiary, Milacron LLC, will undertake a reorganization. After the reorganization, the Milacron Business will be contributed to a new entity, HoldCo, where Purchaser will gain majority ownership. Hillenbrand will receive $287 million in cash and retain approximately 49% equity in HoldCo. The deal is contingent on customary closing conditions, including antitrust evaluations and the absence of any Material Adverse Effect on the Milacron Business. Bain has guaranteed certain obligations under the agreement, with customary termination provisions included.
Additional details:
Purchase Price: 287000000
Equity Interest Retained: 49%
Transaction Closing Conditions: ["expiration of applicable waiting periods","accuracy of representations and warranties","compliance with obligations","completion of reorganization","absence of material adverse effect"]
Termination Provisions: Either party can terminate if the transaction does not close by July 28, 2025. Purchaser may incur a termination fee under specific circumstances.
Form Type: 8-K
Filing Date: 2025-02-05
Corporate Action: Acquisition
Type: New
Accession Number: 000141739825000061
Filing Summary: On February 5, 2025, Hillenbrand, Inc. announced its earnings for the first quarter ended December 31, 2024, along with a press release detailing its results. Furthermore, the Company revealed that it has entered into a transaction for the majority sale of its Milacron injection molding and extrusion business. A conference call to discuss these earnings will take place on February 6, 2025, at 8 a.m. EST, which will be accessible via the Company’s website. The report clarifies that the information provided does not constitute a filing under the Exchange Act, unless referenced specifically.
Additional details:
Item 2 02 Results Of Operations And Financial Condition: Earnings announcement for Q1 ended December 31, 2024.
Item 7 01 Regulation Fd Disclosure: Announcement of majority sale transaction of Milacron business.
Item 9 01 Exhibits: Exhibit 99.1 contains the press release dated February 5, 2025.
Comments
No comments yet. Be the first to comment!